Administered via a once-weekly injection, semaglutide offers convenience and flexibility for patients, allowing them to integrate the treatment into their lifestyle while working towards their health goals
Data were reviewed for two studies: Women with obesity, diabetes, cardiovascular disease and other cardiometabolic disorders have a higher risk of pregnancy complications including preeclampsia, gestational diabetes, stillbirth, C-section and other outcomes
Manufacturer: Victoza and Saxenda (Novo Nordisk)
In two studies of 12- and 24-week duration, SGLT2 inhibitors alone (canagliflozin and dapagliflozin, respectively) did not affect HbA1c levels compared to placebo in overweight and obese subjects [29, 30]
Do not select a CPT code that merely approximates the service provided